Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Change in Account Payables (2018 - 2025)

Historic Change in Account Payables for Serina Therapeutics (SER) over the last 8 years, with Q3 2025 value amounting to $1.0 million.

  • Serina Therapeutics' Change in Account Payables rose 11239.84% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 22577.2%. This contributed to the annual value of -$1.7 million for FY2024, which is 52264.63% down from last year.
  • Per Serina Therapeutics' latest filing, its Change in Account Payables stood at $1.0 million for Q3 2025, which was up 11239.84% from $522000.0 recorded in Q2 2025.
  • In the past 5 years, Serina Therapeutics' Change in Account Payables ranged from a high of $1.2 million in Q3 2023 and a low of -$1.4 million during Q2 2024
  • In the last 5 years, Serina Therapeutics' Change in Account Payables had a median value of -$307000.0 in 2021 and averaged -$68470.6.
  • Per our database at Business Quant, Serina Therapeutics' Change in Account Payables skyrocketed by 47393.94% in 2023 and then tumbled by 63000.0% in 2024.
  • Quarter analysis of 5 years shows Serina Therapeutics' Change in Account Payables stood at -$310000.0 in 2021, then fell by 6.45% to -$330000.0 in 2022, then skyrocketed by 60.61% to -$130000.0 in 2023, then crashed by 630.0% to -$949000.0 in 2024, then surged by 210.12% to $1.0 million in 2025.
  • Its Change in Account Payables was $1.0 million in Q3 2025, compared to $522000.0 in Q2 2025 and $441000.0 in Q1 2025.